Strategies for immunotherapy of cancer
- 1 January 2000
- book chapter
- Published by Elsevier BV in Advances in Immunology
- Vol. 75, 235-282
- https://doi.org/10.1016/s0065-2776(00)75006-1
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancerInternational Journal of Cancer, 1998
- Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoireEuropean Journal of Immunology, 1998
- Much ado about minor histocompatibility antigensImmunology Today, 1998
- Resistance of cultured peripheral T cells towards activation‐induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death‐inducing signaling complexEuropean Journal of Immunology, 1997
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Apoptosis by Death FactorCell, 1997
- Harnessing self-reactivity in cancer immunotherapySeminars in Immunology, 1996
- A Single Residue Exchange Within a Viral CTL Epitope Alters Proteasome-Mediated Degradation Resulting in Lack of Antigen PresentationImmunity, 1996
- A new foreign policy: MHC class I molecules monitor the outside worldImmunology Today, 1996
- A role for CD95 ligand in preventing graft rejectionNature, 1995